BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Figlia V, Mazzola R, Cuccia F, Alongi F, Mortellaro G, Cespuglio D, Cucchiara T, Iacoviello G, Valenti V, Molino M, Verderame F, Matranga D, Casto AL, Ferrera G. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience. Radiol Med 2018;123:406-14. [PMID: 29455424 DOI: 10.1007/s11547-018-0858-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cuccia F, Carruba G, Ferrera G. What We Talk about When We Talk about Artificial Intelligence in Radiation Oncology. JPM 2022;12:1834. [DOI: 10.3390/jpm12111834] [Reference Citation Analysis]
2 Cuccia F, Mazzola R, Figlia V, Giaj-levra N, Nicosia L, Ricchetti F, Rigo M, Attinà G, Vitale C, Pastorello E, Ruggieri R, Alongi F. Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors. Strahlenther Onkol. [DOI: 10.1007/s00066-022-01951-0] [Reference Citation Analysis]
3 Aduquaye M, Dube S, Bashir B, Chowdhury A, Ahmed N, Leylek A, Kim J, Lambert P, Bucher O, Hunter W, Sivananthan G, Koul R, Rathod S. Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy. Current Oncology 2022;29:193-208. [DOI: 10.3390/curroncol29010019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bilski M, Mertowska P, Mertowski S, Sawicki M, Hymos A, Niedźwiedzka-Rystwej P, Grywalska E. The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung. Cancers (Basel) 2021;14:177. [PMID: 35008341 DOI: 10.3390/cancers14010177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang R, Zhang R, Luan T, Liu B, Zhang Y, Xu Y, Sun X, Xing L. A Radiomics Nomogram for Preoperative Prediction of Clinical Occult Lymph Node Metastasis in cT1-2N0M0 Solid Lung Adenocarcinoma. Cancer Manag Res 2021;13:8157-67. [PMID: 34737644 DOI: 10.2147/CMAR.S330824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shao Y, Chen H, Wang H, Feng A, Huang Y, Kong Q, Xu Z. Isotoxic investigation of 18F-FDG PET/CT-guided dose escalation with intensity-modulated radiotherapy for LA-NSCLC. Int J Radiat Biol 2021;97:1641-8. [PMID: 34597214 DOI: 10.1080/09553002.2021.1987557] [Reference Citation Analysis]
7 Ubaldi L, Valenti V, Borgese RF, Collura G, Fantacci ME, Ferrera G, Iacoviello G, Abbate BF, Laruina F, Tripoli A, Retico A, Marrale M. Strategies to develop radiomics and machine learning models for lung cancer stage and histology prediction using small data samples. Phys Med 2021;90:13-22. [PMID: 34521016 DOI: 10.1016/j.ejmp.2021.08.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhang X, Yang D, Jiang Y, Huang L, Wang C, Tao D, Liu X, Lei Y, Wu Y, Zhou W. Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors. J Inflamm Res 2021;14:4205-15. [PMID: 34483676 DOI: 10.2147/JIR.S328955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tong F, Xiong CJ, Wei CH, Wang Y, Liang ZW, Lu H, Pan HJ, Dong JH, Zheng XF, Wu G, Dong XR. Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway. Ther Adv Med Oncol 2020;12:1758835920965853. [PMID: 33193827 DOI: 10.1177/1758835920965853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
10 Kumar S, Mankame DP. Optimization driven Deep Convolution Neural Network for brain tumor classification. Biocybernetics and Biomedical Engineering 2020;40:1190-204. [DOI: 10.1016/j.bbe.2020.05.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
11 Chen H, Laba JM, Zayed S, Boldt RG, Palma DA, Louie AV. Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review. J Thorac Oncol 2019;14:1332-42. [PMID: 31075543 DOI: 10.1016/j.jtho.2019.04.018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
12 Mazzola R, Ruggieri R, Figlia V, Rigo M, Giaj Levra N, Ricchetti F, Nicosia L, Corradini S, Alongi F. Stereotactic body radiotherapy of central lung malignancies using a simultaneous integrated protection approach : A prospective observational study. Strahlenther Onkol. 2019;195:719-724. [PMID: 30689026 DOI: 10.1007/s00066-018-01419-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]